DoD Neurofibromatosis Investigator-Initiated Research Award
The summary for the DoD Neurofibromatosis Investigator-Initiated Research Award grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the Dept of the Army USAMRAA, which is the U.S. government agency offering this grant.
DoD Neurofibromatosis Investigator-Initiated Research Award: The NFRP Investigator-Initiated Research Award supports highly rigorous, high-impact research projects that have the potential to make an important contribution to NF research and/or patient care. Research projects may focus on any phase of research, excluding clinical trials. The rationale for a research idea may be derived from laboratory discovery, population-based studies, a clinician’s firsthand knowledge of patients, or anecdotal data. Applications must include preliminary and/or published data that are relevant to NF and the proposed research project.
Preclinical Research: All projects should adhere to a core set of standards for rigorous study design and reporting to maximize the reproducibility and translational potential of preclinical research. The standards are described in Landis, S.C., et al. A call for transparent reporting to optimize the predictive value of preclinical research, Nature 2012, 490:187-191 (www.nature.com/nature/journal/v490/n7419/full/nature11556.html). While these standards are written for preclinical studies, the basic principles of randomization, blinding, sample-size estimation, and data handling derive from well-established best practices in research and should be applied. Projects that include research on animal models are required to submit Attachment 8, Animal Research Plan, as part of the application package to describe how these standards will be addressed. Applicants should consult the ARRIVE (Animal Research: Reporting In Vivo Experiments) guidelines to ensure relevant aspects of rigorous animal research are adequately planned for and, ultimately, reported. The ARRIVE guidelines can be found at
http://www.elsevier.com/__data/promis_misc/622936arrive_guidelines.pdf.
Preclinical Research: All projects should adhere to a core set of standards for rigorous study design and reporting to maximize the reproducibility and translational potential of preclinical research. The standards are described in Landis, S.C., et al. A call for transparent reporting to optimize the predictive value of preclinical research, Nature 2012, 490:187-191 (www.nature.com/nature/journal/v490/n7419/full/nature11556.html). While these standards are written for preclinical studies, the basic principles of randomization, blinding, sample-size estimation, and data handling derive from well-established best practices in research and should be applied. Projects that include research on animal models are required to submit Attachment 8, Animal Research Plan, as part of the application package to describe how these standards will be addressed. Applicants should consult the ARRIVE (Animal Research: Reporting In Vivo Experiments) guidelines to ensure relevant aspects of rigorous animal research are adequately planned for and, ultimately, reported. The ARRIVE guidelines can be found at
http://www.elsevier.com/__data/promis_misc/622936arrive_guidelines.pdf.
| Federal Grant Title: | DoD Neurofibromatosis Investigator-Initiated Research Award |
| Federal Agency Name: | Dept of the Army USAMRAA |
| Grant Categories: | Science and Technology |
| Type of Opportunity: | Discretionary |
| Funding Opportunity Number: | W81XWH-16-NFRP-IIRA |
| Type of Funding: | Cooperative Agreement, Grant |
| CFDA Numbers: | 322135 |
| CFDA Descriptions: | Military Medical Research and Development |
| Current Application Deadline: | Aug 1, 2016 |
| Original Application Deadline: | Aug 1, 2016 |
| Posted Date: | May 9, 2016 |
| Creation Date: | May 9, 2016 |
| Archive Date: | Aug 31, 2016 |
| Total Program Funding: | $1,680,000 |
| Maximum Federal Grant Award: | none |
| Minimum Federal Grant Award: | none |
| Expected Number of Awards: | 2 |
| Cost Sharing or Matching: | No |
- Applicants Eligible for this Grant
- Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
- Grant Announcement Contact
- CDMRP Help Desk
Phone: 301-682-5507
Email: [email protected]
CDMRP Help Desk
Dept. of the Army -- USAMRAA 301-619-7144